Piramal Pharma Ltd received a US FDA Form 483 with four observations at its Lexington facility, expected as VAI. The company will respond and aims to uphold quality and compliance.
Piramal Pharma Ltd received a US FDA Form 483 with four observations at its Lexington facility, expected as VAI. The company will respond and aims to uphold quality and compliance.